Parasitic worm study predicts potential drug targets and drugs
The largest ever parasitic worm study has revealed nearly 1 million new genes, and has identified potential drug targets and drugs...
List view / Grid view
The largest ever parasitic worm study has revealed nearly 1 million new genes, and has identified potential drug targets and drugs...
Gene therapy could be effective in numerous neurological conditions and could transform the lives of patients with these incurable diseases...
Scientists in the United States have inadvertently uncovered a promising treatment for melanoma that targets the NGLY1 gene.
Investigational therapeutic candidate made with four antibodies tethered together shows promise against influenza A and B...
A biodegradable scaffold used to transplant stem cells and deliver drugs, could help in the treatment of brain diseases...
Charles River Laboratories International, Inc. (NYSE: CRL) announced that its team of neuroscience drug discovery experts will present 26 scientific posters, both independently and collaboratively with clients, at Neuroscience 2018, the 48th annual meeting of the Society for Neuroscience (SfN)...
Researchers have identified biomarkers associated with severe birth defects in babies born to women infected with the Zika virus...
Researchers have managed to image serotonin activating its receptor for the first time using the cutting edge technology, cryo-electron microscopy...
MDM2 inhibitors could be used as a treatment for uveitis, a disease affecting the middle layer of the eye, causing inflammation and redness...
Researchers at the University of Eastern Finland have developed antibacterial compounds based on the action of LsrK kinase...
A biomarker has been discovered for the most common type of heart failure - heart failure with preserved ejection fraction...
An increase in the expression of sugar-burning 'glycolytic' enzymes in precancerous cirrhotic livers has been identified and could be used as a biomarker...
Two ddPCR-based assays were developed to detect the two mutations in the promoter region of the TERT gene, which could be used as biomarkers...
A team of scientists led by Stanford University School of Medicine has identified a link between how proteins bind to our DNA and how cancer develops. This finding may allow researchers to predict cancer pathways and long-term patient outcomes.
The Tn antigen appears in around 90 percent of cancers, and its structure is greatly affected by the addition of water molecules...